Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?
The coronavirus disease (COVID-19) is resulting in millions of infected individuals with several hundred thousands dead throughout the world. Amidst all the havoc, one interesting observation in the present COVID-19 pandemic is the negligible symptoms in the young; particularly children below 10 yea...
Saved in:
Main Authors: | Anand Anbarasu (Author), Sudha Ramaiah (Author), Paul Livingstone (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective
by: Soumya Basu, et al.
Published: (2023) -
MMR Vaccine and Transverse Myelitis
by: J Gordon Millichap
Published: (1995) -
Evaluation of MMR Vaccination and Autism Link
by: J Gordon Millichap
Published: (2002) -
Does BCG Or MMR Or Routine Vaccination Coverage Protect Against COVID Infection And Mortality In India?
by: Shrinivasa Basavewowdanadoddi Marinaik, et al.
Published: (2022) -
MMR-Varicella Vaccine and Risk of Febrile Seizures
by: J Gordon Millichap
Published: (2010)